FDA Approved: FINTEPLA — Original Application (UCB, Inc.)

View source ↗

Summary

FDA approved the original application for Fintepla (fenfluramine) by UCB, Inc., to treat convulsive seizures associated with Dravet syndrome in patients aged 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Fintepla (Fenfluramine)

Snippet

ORIG AP for FINTEPLA (FENFLURAMINE)